Back to Search Start Over

RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior

Authors :
Fernandez N
Gan G
van Donkelaar MMJ
Vaht M
Weber H
Retz W
Meyer-Lindenberg A
Franke B
Harro J
Reif A
Faraone SV
Cormand B
Source :
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, EUROPEAN NEUROPSYCHOPHARMACOLOGY, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu
Publication Year :
2020
Publisher :
ELSEVIER SCIENCE BV, 2020.

Abstract

The RBFOX1 gene (or A2BP1) encodes a splicing factor important for neuronal development that has been related to autism spectrum disorder and other neurodevelopmental phenotypes. Evidence from complementary sources suggests that this gene contributes to aggressive behavior. Suggestive associations with RBFOX1 have been identified in genome-wide association studies (GWAS) of anger, conduct disorder, and aggressive behavior. Nominal association signals in RBFOX1 were also found in an epigenome-wide association study (EWAS) of aggressive behavior. Also, variants in this gene affect temporal lobe volume, a brain area that is altered in several aggression-related phenotypes. In animals, this gene has been shown to modulate aggressive behavior in Drosophila. RBFOX1 has also been associated with canine aggression and is upregulated in mice that show increased aggression after frustration of an expected reward. Associated common genetic variants as well as rare duplications and deletions affecting RBFOX1 have been identified in several psychiatric and neurodevelopmental disorders that are often comorbid with aggressive behaviors. In this paper, we comprehensively review the cumulative evidence linking RBFOX1 to aggression behavior and provide new results implicating RBFOX1 in this phenotype. Most of these studies (genetic and epigenetic analyses in humans, neuroimaging genetics, gene expression and animal models) are hypothesis-free, which strengthens the validity of the findings, although all the evidence is nominal and should therefore be taken with caution. Further studies are required to clarify in detail the role of this gene in this complex phenotype.

Details

ISSN :
18737862 and 0924977X
Database :
OpenAIRE
Journal :
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, EUROPEAN NEUROPSYCHOPHARMACOLOGY, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu
Accession number :
edsair.dedup.wf.001..320d729ec46a6d480f99df03fe580e0e